Evidence map›Paper›PMID 22132074›Full record

ArticlePloS one2011

A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface.

Xiaoxiao Li, James LeBlanc, Allison Truong, Ravi Vuthoori, Sharon S Chen, Jonathan L Lustgarten, Bennett Roth, Jeff Allard, Andrew Ippoliti, Laura L Presley and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Metaproteomics Analysis of Host-Microbiota Interfaces.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Chronic kidney disease and the gut microbiome.American journal of physiology. Renal physiology · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Xiaoxiao LiDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America.
James LeBlanc
Allison Truong
Ravi Vuthoori
Sharon S Chen
Jonathan L Lustgarten
Bennett Roth
Jeff Allard
Andrew Ippoliti
Laura L Presley
James Borneman
William L Bigbee
Vanathi Gopalakrishnan
Thomas G Graeber
David Elashoff
Jonathan Braun
Lee Goodglick
University of California, Los Angeles · USUniversity of California, Riverside · USUniversity of Pittsburgh · USCedars-Sinai Medical Center · USUPMC Hillman Cancer Center · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
UCLA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR033176 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2011 to 2011
$15.5M
Identifying Microorganisms involved in Human Health and Disease ProcessesR01AI078885 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI BORNEMAN, JAMES · 2008 to 2011
$1.4M
NCI NIH HHS P30 CA016042NCRR NIH HHS UL1 RR033176NIAID NIH HHS AI078885NIAID NIH HHS AI28697NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI078885NIDDK NIH HHS DK46763NIDDK NIH HHS P01 DK046763
6 · The paper itself

Abstract

Aberrant interactions between the host and the intestinal bacteria are thought to contribute to the pathogenesis of many digestive diseases. However, studying the complex ecosystem at the human mucosal-luminal interface (MLI) is challenging and requires an integrative systems biology approach. Therefore, we developed a novel method integrating lavage sampling of the human mucosal surface, high-throughput proteomics, and a unique suite of bioinformatic and statistical analyses. Shotgun proteomic analysis of secreted proteins recovered from the MLI confirmed the presence of both human and bacterial components. To profile the MLI metaproteome, we collected 205 mucosal lavage samples from 38 healthy subjects, and subjected them to high-throughput proteomics. The spectral data were subjected to a rigorous data processing pipeline to optimize suitability for quantitation and analysis, and then were evaluated using a set of biostatistical tools. Compared to the mucosal transcriptome, the MLI metaproteome was enriched for extracellular proteins involved in response to stimulus and immune system processes. Analysis of the metaproteome revealed significant individual-related as well as anatomic region-related (biogeographic) features. Quantitative shotgun proteomics established the identity and confirmed the biogeographic association of 49 proteins (including 3 functional protein networks) demarcating the proximal and distal colon. This robust and integrated proteomic approach is thus effective for identifying functional features of the human mucosal ecosystem, and a fresh understanding of the basic biology and disease processes at the MLI.

Indexed as

EcosystemBiopsyFemaleHealthHumansIntestinal MucosaMaleMiddle AgedMolecular Sequence AnnotationPhylogenyProteomeProteomicsReproducibility of ResultsSpecimen HandlingTranscriptomeProteome

Identifiers

PMID22132074
PMCPMC3221670
OpenAlexW2157389697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.